RxDoctor Payments Data

Gavin Schwarz, MD

Allergy & Immunology · West Hartford, CTNPI 1093848988

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $235,103 of the $262,420 with a category attached, or 89.6%. 14 manufacturers reported payments, led by Sanofi at 38.0% of the total. Among allergy & immunology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$262,420in general payments, 2019–2025

Across 329 payments — averaging $797.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$100K
  • Regeneron Healthcare Solutions, Inc.$55K
  • Grifols USA, LLC$38K
  • AstraZeneca$26K
  • Pfizer$23K
  • Shire North American Group Inc$9K
  • plus $11K from 8 others
$39,407in research payments, 2019–2025

Across 35 payments — averaging $1125.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$39K

What the payments were for

  • Consulting fees$2,2551%
  • Speaking & faculty fees$235,10390%
  • Travel & lodging$15,2166%
  • Food & beverage$9,8334%
  • Education$130%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$262,420 in reported general payments places this provider in the 95th percentile of 54 allergy & immunology providers in Connecticut.

See all allergy & immunology providers in Connecticut

Medicare billing

Part B allowed, 2024
$3,456
Medicare patients
14
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$13,137
Epinephrine13$2,619
Albuterol Sulfate HfaAlbuterol Sulfate18$574

Paid to pharmacies, not to this prescriber.

Other allergy & immunology in West Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →